J. Ohyashiki

发表

Translocation (2;16)(p11;q22) and trisomy 22 in acute myelogenous leukemia (FAB M2) with bone marrow eosinophilia.

T. Tauchi, K. Ohyashiki, T. Murakami, 1991, Cancer genetics and cytogenetics.

Acute myelomonocytic leukemia with inv(16)(p13q22) in an XY/XYY male.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1987, Cancer genetics and cytogenetics.

Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.

H. Kato, J. Shay, W. Wright, 1997, Cancer research.

Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

J. Shay, K. Ohyashiki, J. Ohyashiki, 1997, Leukemia.

Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes.

K. Ohyashiki, J. Ohyashiki, J. Ohyashiki, 1994, Cancer research.

MEIS1 and HOXA7 genes in human acute myeloid leukemia.

K. Takeshita, J. E. Smith, K. Ohyashiki, 2000, Leukemia research.

The Wilms’ tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes

M. Tomonaga, K. Aozasa, Kazushi Inoue, 1999, Leukemia.

Recurrent chromosomal aberration at 12q15 in chronic idiopathic myelofibrosis with or without JAK2V617F mutation

T. Tauchi, K. Ohyashiki, A. Kodama, 2007, Leukemia.

GATA-1, GATA-2, and stem cell leukemia gene expression in acute myeloid leukemia.

S. Nakazawa, K. Ohyashiki, J. Ohyashiki, 1994, Leukemia.

Molecular genetic, cytogenetic, and immunophenotypic analyses in Castleman's disease of the plasma cell type.

A. Mikata, K. Ohyashiki, J. Ohyashiki, 1994, American journal of clinical pathology.

Presence of Philadelphia (Ph) chromosome-negative cells in Ph-positive chronic myelogenous leukemia.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1990, Japanese journal of medicine.

ETS1 gene in myelodysplastic syndrome with chromosome change at 11q23.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1990, Cancer Genetics and Cytogenetics.

Molecular and clinical investigations in Philadelphia chromosome-negative chronic myelogenous leukemia.

K. Ohyashiki, J. Ohyashiki, H. Ito, 1988, Cancer genetics and cytogenetics.

Analysis of DNA from cells fixed in Carnoy's solution for cytogenetic study.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1988, Cancer genetics and cytogenetics.

Clinical and biologic characteristics of CD7+ acute myeloid leukemia. Our experience and literature review.

S. Nakazawa, K. Ohyashiki, J. Miyauchi, 1994, Cancer genetics and cytogenetics.

Human cord blood-derived primitive progenitors are enriched in CD34+c-kit− cells: correlation between long-term culture-initiating cells and telomerase expression

Y. Sonoda, H. Minamiguchi, K. Ohyashiki, 1998, Leukemia.

Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1996, Leukemia & lymphoma.

Clinical implications of telomerase activity levels in acute leukemia.

J. Shay, K. Ohyashiki, J. Ohyashiki, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: possible association with GATA-1, GATA-2, and stem cell leukemia gene expression.

S. Nakazawa, K. Ohyashiki, J. Ohyashiki, 1995, Blood.

Trisomy of chromosome 8 in myelodysplastic syndrome. Significance of the fluctuating trisomy 8 population.

I. Sasao, K. Ohyashiki, T. Murakami, 1992, Cancer genetics and cytogenetics.

Clinical aspects, cytogenetics and disease evolution in myelodysplastic syndromes.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1996, Leukemia & lymphoma.

Myelodysplastic syndrome evolving into a myeloproliferative disorder: one disease or two?

S. Komatsumoto, K. Ohyashiki, T. Kuratsuji, 1993, Leukemia.

Central nervous system involvement in acute nonlymphocytic leukemia with inv(16)(p13q22).

K. Ohyashiki, H. Ito, J. Ohyashiki, 1988, Leukemia.

Chromosome change at 16q22 in nonlymphocytic leukemia: clinical implication on leukemia patients with inv(16) versus del(16).

K. Ohyashiki, H. Ito, J. Ohyashiki, 1988, Leukemia.

Leukemic phase of intermediate non-Hodgkin's lymphoma with cells showing different matured stages in invaded various organs.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1992, Internal medicine.

Late appearance of a Philadelphia translocation with minor-BCR/ABL transcript in a t(7;11)(p15;p15) acute myeloid leukemia.

S. Aizawa, K. Ohyashiki, K. Miyazawa, 1995, Leukemia.

Two additional cases of acute myeloid leukemia with t(7;11)(p15;p15) having low neutrophil alkaline phosphatase scores.

K. Ohyashiki, A. Kodama, J. Ohyashiki, 1993, Cancer genetics and cytogenetics.

Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia: a pilot study which raises important questions.

S. Nakazawa, H. Hojo, T. Tauchi, 1991, Leukemia.

Elevated plasma level of differentiation inhibitory factor nm23-H1 protein correlates with risk factors for myelodysplastic syndrome

Y. Honma, K. Ohyashiki, J. Okabe‐Kado, 2002, Leukemia.

Late appearance of t(5;12)(q31;p12) in acute myeloid leukemia associated with eosinophilia.

K. Ohyashiki, K. Miyazawa, Y. Kimura, 1998, Cancer genetics and cytogenetics.

Correction of anaemia in rheumatoid arthritis by recombinant human erythropoietin.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1990, British journal of rheumatology.

Cytogenetic and immunogenotypic alterations of blast crisis cells in chronic myelogenous leukemia independently linked to immunophenotypic expression.

S. Nakazawa, T. Tauchi, K. Ohyashiki, 1994, Cancer genetics and cytogenetics.

In vitro cytogenetic effects of recombinant human hematopoietic growth factors on cells derived from myelodysplastic syndromes.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1990, Cancer genetics and cytogenetics.

Cytogenetic findings in adult acute leukemia and myeloproliferative disorders with an involvement of megakaryocyte lineage

S. Nakazawa, H. Hojo, K. Ohyashiki, 1990, Cancer.

Translocation t(3;4)(q26;q21) in myelodysplastic syndrome with megakaryoblastic proliferation.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1988, Cancer genetics and cytogenetics.

Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1992, Cancer genetics and cytogenetics.

Myelodysplastic syndrome with trisomy 11 associated with polycythemia vera

H. Hojo, K. Ohyashiki, H. Hojo, 1989, American journal of hematology.

Establishment of a novel heterotransplantable acute lymphoblastic leukemia cell line with a t(17;19) chromosomal translocation the growth of which is inhibited by interleukin-3.

S. Nakazawa, S. Clark, T. Tauchi, 1991, Leukemia.

The expression pattern of erythrocyte/megakaryocyte-related transcription factors GATA-1 and the stem cell leukemia gene correlates with hematopoietic differentiation and is associated with outcome of acute myeloid leukemia.

S. Nakazawa, K. Ohyashiki, J. Ohyashiki, 1995, Blood.

Hypomethylated status, but not RAG-1, is required for T-cell receptor-beta-chain gene rearrangement in acute leukemia cells.

S. Nakazawa, T. Tauchi, K. Ohyashiki, 1994, Cancer genetics and cytogenetics.

Methylation status of T-cell receptor beta-chain gene in B precursor acute lymphoblastic leukemia: correlation with hypomethylation and gene rearrangement.

S. Nakazawa, T. Tauchi, K. Ohyashiki, 1991, Cancer research.

Therapy for Philadelphia chromosome-positive acute lymphoblastic leukemia: possible use of interferon on the basis of some novel concepts.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1993, Leukemia & lymphoma.

Telomere shortening in leukemic cells is related to their genetic alterations but not replicative capability.

S. Nakazawa, K. Ohyashiki, J. Ohyashiki, 1994, Cancer genetics and cytogenetics.

Telomerase reactivation in leukemia cells.

K. Ohyashiki, J. Ohyashiki, K. Toyama, 1996, International journal of oncology.

Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line, OM9;22.

Y. Matsuo, S. Nakazawa, S. Mizutani, 1993, Leukemia.

Immunogenotypes and clonal culture analysis in B-precursor acute lymphoblastic leukemia.

S. Nakazawa, S. Clark, T. Tauchi, 1992, Leukemia.

Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.

S. Nakazawa, T. Tauchi, K. Ohyashiki, 1990, Leukemia.

Do leukemia patients with chromosome 16 inversion--inv(16)(p13q22)--have a rare fragile site at 16q22?

K. Ohyashiki, H. Ito, J. Ohyashiki, 1988, Cancer genetics and cytogenetics.

A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantation

K. Ohyashiki, N. Shimizu, K. Yamamoto, 2001, Bone Marrow Transplantation.

Replication errors in hematological neoplasias: genomic instability in progression of disease is different among different types of leukemia.

S. Aizawa, K. Ohyashiki, J. Ohyashiki, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Near-hexaploid Ph-positive acute myeloid leukemia with major-BCR/ABL transcript.

K. Ohyashiki, A. Kodama, J. Ohyashiki, 1996, Cancer genetics and cytogenetics.

Technical report A rapid monitoring system of human herpesviruses reactivation by LightCycler in stem cell transplantation

K. Ohyashiki, N. Shimizu, J. Ohyashiki, 2001 .

The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1993, Leukemia.

T-cell receptor beta chain gene rearrangement in acute myeloid leukemia always occurs at the allele that contains the undermethylated J beta 1 region.

S. Nakazawa, T. Tauchi, K. Ohyashiki, 1992, Cancer research.

High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.

J. Okamura, M. Kikuchi, T. Uchida, 1996, Leukemia.

Clinical and cytogenetic significance of myelodysplastic syndromes with disease evolution.

I. Sasao, K. Ohyashiki, H. Ito, 1993, Cancer genetics and cytogenetics.

Double-minute chromosomes appearing in a patient with myelodysplastic syndrome with disease evolution.

K. Ohyashiki, T. Murakami, J. Ohyashiki, 1995, Cancer genetics and cytogenetics.

Thrombosis can occur at any phase of essential thrombocythemia with JAK2V617F mutation: a single institutional study in Japan

K. Ohyashiki, J. Ohyashiki, Yoshikazu Ito, 2007, Leukemia.

Phenotypic and molecular analysis of ph1‐chromosome‐positive acute lymphoblastic leukemia cell lines

K. Yamato, I. Miyoshi, J. Ohyashiki, 1993, International journal of cancer.

A Ki-1 (CD30)-positive T (E+, CD4+, Ia+)-cell line, DL-40, established from aggressive large cell lymphoma.

Y. Ohtsuki, H. Sonobe, K. Ohyashiki, 1990, Cancer research.

Myelodysplastic syndrome with Philadelphia-like chromosome without bcr rearrangement.

K. Ohyashiki, J. Ohyashiki, J. Ohyashiki, 1988, Cancer genetics and cytogenetics.

A patient with pure red cell aplasia and Good's syndrome.

T. Tauchi, K. Ohyashiki, J. Ohyashiki, 1999, Haematologica.

Double 20q- anomaly in myelodysplastic syndrome.

K. Ohyashiki, N. Sakai, H. Ito, 1992, Cancer genetics and cytogenetics.

[Transient hypofibrinogenemia induced by prednisolone in a case of acute lymphoblastic leukemia].

H. Hojo, K. Ohyashiki, J. Ohyashiki, 1989, [Rinsho ketsueki] The Japanese journal of clinical hematology.

EVI1 expression associated with a 3q26 anomaly in a leukemia cell line derived from the blast crisis of chronic myeloid leukemia.

S. Nakazawa, K. Suzukawa, K. Ohyashiki, 1994, Leukemia.

Two Additional Acute Nonlymphocytic Leukemia Patients with a Sole Chromosome Abnormality of Trisomy 4.

T. Tauchi, K. Ohyashiki, A. Kodama, 1990, Leukemia & lymphoma.

Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2V617F mutational status

A. Gotoh, T. Tauchi, K. Ohyashiki, 2007, Leukemia.

[Clinical study of rhG-CSF (KRN8601) in patients with myelodysplastic syndrome].

K. Miyazono, H. Mizoguchi, F. Takaku, 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology.

Detection and quantification of human herpesvirus 6 genomes using bronchoalveolar lavage fluid in immunocompromised patients with interstitial pneumonia.

K. Ohyashiki, I. Kasuga, K. Abe, 2001, International Journal of Molecular Medicine.

Telomere length shortening in patients with dementia with Lewy bodies

H. Hanyu, H. Sakurai, T. Iwamoto, 2012, European journal of neurology.